Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in behavioral and psychological symptoms of severe Alzheimer's disease
2007-004918-14Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Pfizer. Primary endpoint: Combined Cornell Scale for Depression in Dementia Mood-related Signs and Behavioural Disturbance domains. Started Mar 2008; status: terminated.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-004918-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004918-14.